Published in Clin Exp Immunol on January 01, 1977
Identification of human mononuclear leucocyte populations by esterase staining. Clin Exp Immunol (1977) 3.12
Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J Clin Invest (1982) 3.10
Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function. J Clin Invest (1980) 1.68
Lymphocyte reactivity to mitogens in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma. Clin Exp Immunol (1977) 1.39
Use of the ELISA to screen for anti-thymocyte and anti-beta 2-microglobulin antibodies in leprosy and SLE. Immunology (1980) 1.22
Immune function in systemic lupus erythematosus. Impairment of in vitro T-cell proliferation and in vivo antibody response to exogenous antigen. J Clin Invest (1979) 1.19
Human blood L lymphocytes in patients with active systemic lupus erythematosus, rheumatoid arthritis and scleroderma: a comparison with T and B cells. Clin Exp Immunol (1977) 1.00
Relationship between T cell subpopulations and the mitogen responsiveness and suppressor cell function of peripheral blood mononuclear cells in normal individuals. Clin Exp Immunol (1980) 0.93
Inhibition of soluble antigen-induced T cell proliferation by warm-reactive antibodies to activated T cells in systemic lupus erythematosus. J Clin Invest (1984) 0.92
Mitogen responsiveness in viral hepatitis and chronic active hepatitis: the role of reversible suppressive influences. Gut (1980) 0.81
Inhibition of proliferative and suppressor responses in the autologous mixed lymphocyte reaction by serum from patients with systemic lupus erythematosus. Ann Rheum Dis (1982) 0.80
Systemic lupus erythematosus--an autoimmune disease? J Clin Pathol Suppl (R Coll Pathol) (1978) 0.75
Cytotoxins in disease. Autocytotoxins in lupus. N Engl J Med (1970) 4.40
Analyses of lymphocytes from patients with rheumatoid arthritis and systemic lupus erythematosus. Occurrence of interfering cold-reactive antilymphocyte antibodies. J Clin Invest (1974) 3.24
Immunostimulant therapy with levamisole for rheumatoid arthritis. Lancet (1976) 3.07
Characterizaiton of two populations of human lymphocytes bearing easily detectable surface immunoglobulin. J Clin Invest (1975) 2.78
Impaired Lymphocyte Transformation and Delayed Hypersensitivity in Sjögren's Syndrome. J Clin Invest (1967) 2.77
Nature of cold-reactive antibodies to lymphocyte surface determinants in systemic lupus erythematosus. Arthritis Rheum (1975) 2.65
Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor. J Exp Med (1972) 2.20
Antibodies to a specific surface antigen of T cells in human sera inhibiting mixed leukocyte culture reactions. J Exp Med (1973) 2.11
Cellular immunity in rheumatic diseases. I. Rheumatoid arthritis. Arthritis Rheum (1973) 1.83
Inhibition of mixed leukocyte culture responses by serum and gamma-globulin fractions from certain patients with connective tissue disorders. Arthritis Rheum (1973) 1.63
Suppression of lymphocyte transformation after aspirin ingestion. N Engl J Med (1975) 1.52
Immunologic reactivity in rheumatoid arthritis. Response to mitogens. Arthritis Rheum (1974) 1.52
Lymphocyte activation. V. Quantitation of the proliferative responses to mitogens using defined T and B cell populations. Clin Exp Immunol (1973) 1.52
The effect of plasma upon lymphocyte response in vitro. Demonstration of a humoral inhibitor in patients with sarcoidosis. Clin Exp Immunol (1974) 1.51
A relationship between impaired cellular immunity humoral suppression of lymphocyte function and severity of systemic lupus erythematosus. Am J Med (1975) 1.50
The effect of salicylate on the metabolism of normal and stimulated human lymphocytes in vitro. J Clin Invest (1971) 1.50
Suppression of lymphocyte transformation by aspirin. Lancet (1973) 1.43
Lymphocyte reactivity to mitogens in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma. Clin Exp Immunol (1977) 1.39
Effect of anti-lymphocyte serum on responses of human peripheral-blood lymphocytes to specific and non-specific stimulants in vitro. Lancet (1967) 1.16
Characterization of a serum inhibitor of MLC reactions. Clin Exp Immunol (1973) 1.14
Impaired responsiveness of lymphocytes in patients with systemic lupus erythematosus. Clin Exp Immunol (1974) 1.07
The effect of antilymphocyte antibody on lymphocyte transformation. Selective suppression of mitogen, mixed lymphocyte culture, and antigen stimulation of human lymphocytes. Transplantation (1974) 0.86
In vitro stimulation or inhibition of lymphocyte activation by antilymphocyte serum. Transplant Proc (1971) 0.81
Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann Intern Med (1999) 6.84
Identification of two populations of immunoglobulin-bearing lymphocytes in man. J Immunol (1975) 3.83
A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. J Immunol (2001) 3.63
Identification of human mononuclear leucocyte populations by esterase staining. Clin Exp Immunol (1977) 3.12
Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J Immunol (1983) 2.95
Characterizaiton of two populations of human lymphocytes bearing easily detectable surface immunoglobulin. J Clin Invest (1975) 2.78
Apathy is not depression. J Neuropsychiatry Clin Neurosci (1998) 2.24
Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor. J Exp Med (1972) 2.20
Broadband observations of the naked-eye gamma-ray burst GRB 080319B. Nature (2008) 2.16
An appraisal of Fc receptors on human peripheral blood B and L lymphocytes. J Immunol (1976) 2.05
Impaired delayed hypersensitivity in systemic lupus erythematosus. Arthritis Rheum (1972) 1.88
Evidence by reactivity with hybridoma antibodies for a probable myeloid origin of peripheral blood cells active in natural cytotoxicity and antibody-dependent cell-mediated cytotoxicity. J Clin Invest (1980) 1.78
In situ identification of cells in human leprosy granulomas with monoclonal antibodies to interleukin 2 and its receptor. J Immunol (1984) 1.74
The development of macrophages from large mononuclear cells in the blood of patients with inflammatory disease. J Clin Invest (1972) 1.60
Distinctive functional properties of human blood L lymphocytes: a comparison with T lymphocytes, B lymphocytes, and monocytes. J Immunol (1977) 1.57
Suppressor T lymphocytes from lepromatous leprosy skin lesions. J Immunol (1986) 1.55
A relationship between impaired cellular immunity humoral suppression of lymphocyte function and severity of systemic lupus erythematosus. Am J Med (1975) 1.50
The relationship between defects in lymphocyte production of transforming growth factor-beta1 in systemic lupus erythematosus and disease activity or severity. Lupus (1999) 1.45
Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation. Arthritis Rheum (1988) 1.41
Lymphocyte reactivity to mitogens in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma. Clin Exp Immunol (1977) 1.39
Spontaneous and induced cytotoxic properties of human adherent mononuclear cells: killing of non-sensitized and antibody-coated non-erythroid cells. Immunology (1979) 1.24
Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus. Arthritis Rheum (1998) 1.24
A mildly relativistic radio jet from the otherwise normal type Ic supernova 2007gr. Nature (2010) 1.21
Circulating deoxyribonucleic acid--synthesizing mononuclear leukocytes. I. Increased numbers of proliferating mononuclear leukocytes in inflammatory disease. J Lab Clin Med (1970) 1.20
Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus. J Immunol (1998) 1.20
CD8+ lymphocytes from patients with systemic lupus erythematosus sustain, rather than suppress, spontaneous polyclonal IgG production and synergize with CD4+ cells to support autoantibody synthesis. Arthritis Rheum (1990) 1.19
Correction of interleukin-2 production in patients with systemic lupus erythematosus by removal of spontaneously activated suppressor cells. J Clin Invest (1985) 1.18
Methyldopa inhibition of suppressor-lymphocyte function: a proposed cause of autoimmune hemolytic anemia. N Engl J Med (1980) 1.15
Dementia with Lewy bodies: reliability and validity of clinical and pathologic criteria. Neurology (1996) 1.13
Pseudomonas botryomycosis. Arch Dermatol (1976) 1.11
Abnormalities in autologous mixed lymphocyte reaction-activated immunologic processes in systemic lupus erythematosus and their possible correction by interleukin 2. Eur J Immunol (1985) 1.11
Surface markers and electron microscopy of human blood L cells: a comparison with T and B lymphocytes. J Immunol (1978) 1.08
Potential roles of hypochlorous acid and N-chloroamines in collagen breakdown by phagocytic cells in synovitis. Free Radic Biol Med (1993) 1.06
Further characterization of low density mononuclear cells: FACS-assisted analysis of human MLR stimulators. J Immunol (1985) 1.02
Conditions required for Fc-dependent immune complex enhancement of antigen-specific lymphocyte blastogenesis. J Immunol (1980) 1.02
The role of transforming growth factor beta in the generation of suppression: an interaction between CD8+ T and NK cells. J Exp Med (1994) 1.01
Monocyte and NK cell cytotoxic activity in human adherent cell preparations: discriminating effects of interferon and lactoferrin. J Immunol (1984) 1.00
Human blood L lymphocytes in patients with active systemic lupus erythematosus, rheumatoid arthritis and scleroderma: a comparison with T and B cells. Clin Exp Immunol (1977) 1.00
Contrasting effects of lactoferrin on human lymphocyte and monocyte natural killer activity and antibody-dependent cell-mediated cytotoxicity. J Immunol (1982) 0.98
Interleukin 2 gene therapy of colorectal carcinoma with autologous irradiated tumor cells and genetically engineered fibroblasts: a Phase I study. Clin Cancer Res (1999) 0.98
Histochemical studies for 5'-nucleotidase and alpha-naphthyl (non-specific) esterase in lymphocytes from patients with primary immunoglobulin deficiencies. Clin Exp Immunol (1979) 0.98
Activated human NK cells can stimulate resting B cells to secrete immunoglobulin. J Immunol (1995) 0.97
T lymphocyte subsets in systemic lupus erythematosus. Correlations with corticosteroid therapy and disease activity. Arthritis Rheum (1983) 0.96
Generation of an inhibitory circuit involving CD8+ T cells, IL-2, and NK cell-derived TGF-beta: contrasting effects of anti-CD2 and anti-CD3. J Immunol (1998) 0.96
Tissue and blood T-lymphocyte subpopulations in erythema nodosum leprosum. Arch Dermatol (1985) 0.95
Transforming growth factor beta enhances the expression of CD154 (CD40L) and production of tumor necrosis factor alpha by human T lymphocytes. Immunol Lett (2001) 0.93
Characterization of a non-T, non-B human blood lymphocyte that mediates the enhancing effects of immune complexes on lymphocyte blastogenesis. J Immunol (1980) 0.89
Disseminated Strongyloides stercoralis infection. Association with ectopic ACTH syndrome and depressed cell-mediated immunity. Arch Intern Med (1978) 0.89
Cytokine-mediated down-regulation of B cell activity in SLE: effects of interleukin-2 and transforming growth factor-beta. Lupus (1999) 0.88
An expanding radio nebula produced by a giant flare from the magnetar SGR 1806-20. Nature (2005) 0.88
Rheumatoid vasculitis: effect of cyclophosphamide on the clinical course and levels of circulating immune complexes. Ann Intern Med (1980) 0.88
B and L lymphocytes in primary hypogammaglobulinaemia. Lancet (1977) 0.88
Selective depletion of Ig-bearing lymphocytes by cyclophosphamide in rheumatoid arthritis and systemic lupus erythematosus. Guidelines for dosage. Arthritis Rheum (1974) 0.87
Extracellular accumulation of proline, serine and trehalose in the haemolymph of osmoconforming brackish-water mosquitoes. J Exp Biol (1987) 0.87
Studies on human blood lymphocytes with iC3b (type 3) complement receptors. II. Characterization of subsets which regulate pokeweed mitogen-induced lymphocyte proliferation and immunoglobulin synthesis. Clin Exp Immunol (1987) 0.86
Lymphocytes expressing type 3 complement receptors proliferate in response to interleukin 2 and are the precursors of lymphokine-activated killer cells. J Clin Invest (1988) 0.85
Characterization of immunologic function in homosexual men with persistent, generalized lymphadenopathy and acquired immune deficiency syndrome. Cancer (1987) 0.85
Human resting B lymphocytes can serve as accessory cells for anti-CD2-induced T cell activation. J Immunol (1992) 0.84
Characterization of lymphocytes that suppress IL-2 production in systemic lupus erythematosus. Clin Exp Immunol (1988) 0.84
Impaired recovery and cytolytic function of CD56+ T and non-T cells in systemic lupus erythematosus following in vitro polyclonal T cell stimulation. Studies in unselected patients and monozygotic disease-discordant twins. Arthritis Rheum (1996) 0.82
Natural cytotoxicity of adherent cells from human blood: role of the Fc receptor. J Immunol (1980) 0.80
Antigenic and immunologic characterization of an allogeneic colon carcinoma vaccine. Clin Exp Immunol (2002) 0.79
Studies on human blood lymphocytes with iC3b (type 3) complement receptors: III. Abnormalities in patients with active systemic lupus erythematosus. Clin Exp Immunol (1987) 0.78
Immunologic studies in patients with chyluria. J Clin Immunol (1985) 0.78
A novel role for accessory cells in T cell-dependent B cell differentiation. Cell Immunol (1990) 0.78
Peripheral blood T lymphocyte subsets in leprosy. Int J Lepr Other Mycobact Dis (1984) 0.78
Further characterization of interleukin-2 production by lymphocytes of patients with systemic lupus erythematosus. J Rheumatol (1988) 0.78
Impaired cytotoxic T lymphocyte activity in systemic lupus erythematosus following in vitro polyclonal T cell stimulation: a contributory role for non-T cells. Lupus (1999) 0.78
Immunopathologic demonstration of T lymphocyte subpopulations and interleukin 2 in granuloma annulare. Pediatr Dermatol (1984) 0.77
Binding characteristics of Fc receptors for IgG on human peripheral blood T gamma lymphocytes and "L" lymphocytes: a technical report. Clin Immunol Immunopathol (1979) 0.77
Defective monocyte cytotoxicity in rheumatoid arthritis: a correlation with disease activity and reversal by levamisole. Arthritis Rheum (1982) 0.77
Functional properties of CD8 positive lymphocyte subsets in systemic lupus erythematosus. J Rheumatol Suppl (1987) 0.76
Evidence for tumor-specific immune response in patients with primary brain tumors. Surg Forum (1972) 0.76
Peripheral blood CD4+ T cells in systemic lupus erythematosus. Lupus (2001) 0.75
Human CD8+ lymphocytes stimulated in the absence of CD4+ cells enhance IgG production by antibody-secreting B cells. Clin Immunol Immunopathol (1991) 0.75
Corrigendum: A large light-mass component of cosmic rays at 10(17)-10(17.5) electronvolts from radio observations. Nature (2016) 0.75
Suprapubic versus urethral bladder drainage in patients undergoing intracavitary radium. J Reprod Med (1974) 0.75
Inhibition of collagenase activity by N-chlorotaurine, a product of activated neutrophils. Arthritis Rheum (1994) 0.75
Enhancing effects of interleukin 2-treated peripheral blood mononuclear cells on subsequent B cell differentiation. Cell Immunol (1994) 0.75
Regulation of antigen-induced lymphoproliferation by BSA gradient-separated T cell fractions. J Immunol (1981) 0.75
[Immune functions of patients with systemic lupus erythematosus: abnormalities of immune regulatory circuits activated by autologous mixed lymphocyte reactions and their correction by addition of interleukin 2]. Nihon Naika Gakkai Zasshi (1983) 0.75
Changing concepts of systemic lupus erythematosus. Compr Ther (1978) 0.75
Uterine rupture following attempted saline abortion with oxytocin in a grandmultiparous patient. Obstet Gynecol (1974) 0.75
Mitogen stimulation of human lymphocytes. II. Effect of exogenous DNA on lymphocyte function in systemic lupus erythematosus. Clin Immunol Immunopathol (1982) 0.75
Mitogen stimulation of human lymphocytes. I. The effect of exogenous deoxyribonucleic acid. Clin Immunol Immunopathol (1980) 0.75
Synchronous x-ray and radio mode switches: a rapid global transformation of the pulsar magnetosphere. Science (2013) 0.75
Diagnostic flexible bronchoscopy in human immunodeficiency virus (HIV)-positive children. Int J Pediatr Otorhinolaryngol (1989) 0.75
Ultrastructure of osmoregulatory organs in larvae of the brackish-water mosquito, Culiseta inornata (Williston). J Morphol (1984) 0.75
Technic of intraperitoneal instillation of radioactive colloids. Obstet Gynecol (1973) 0.75
Clinical and immunologic studies in identical twins discordant for systemic lupus erythematosus. Am J Med (1973) 0.75